Increased CD36 expression in neutrophils within the tumor microenvironment may reflect adaptive mechanisms related to lipid-driven immune suppression, as observed in other cancers [12].These findings suggest that both CD18 and CD36 may contribute to neutrophil-mediated immune suppression, although further studies are needed to confirm these mechanisms in OSCC. This evidence concerns the gene ITGB2 and cancer.